Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Weber

Showing results (451-460 of 491) with videos related to

Pageof 50
Sort By:
Wiener Klinische Wochenschrift|December 1, 2021
[Guideline S1: Long COVID: Diagnostics and treatment strategies]Susanne Rabady, Johann Altenberger, Markus Brose, et al.
Wiener Klinische Wochenschrift|August 9, 2023
[S1 guidelines for the management of postviral conditions using the example of post-COVID-19]Susanne Rabady, Kathryn Hoffmann, Martin Aigner, et al.
Wiener Klinische Wochenschrift|December 3, 2020
Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statementDiana Bonderman, Gerhard Pölzl, Klemens Ablasser, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2013
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohortTomas Olsson, Anat Achiron, Lars Alfredsson, et al.
Atherosclerosis|June 29, 2015
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) SocietyCharalambos Vlachopoulos, Panagiotis Xaplanteris, Victor Aboyans, et al.
Hemasphere|January 14, 2022
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell LymphomaRoch Houot, Viola Poeschel, Bettina Altmann, et al.
Journal of Hematology & Oncology|May 21, 2026
Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysisNico Gagelmann, Hermann Einsele, Sarah Flossdorf, et al.
European Heart Journal|August 17, 2025
Accelerated vascular ageing after COVID-19 infection: the CARTESIAN studyRosa Maria Bruno, Smriti Badhwar, Leila Abid, et al.
Journal of Clinical Medicine|July 18, 2020
Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot SpotsMichaela Auer-Grumbach, Rene Rettl, Klemens Ablasser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2023
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient OutcomesDaniel Noerenberg, Franziska Briest, Cornelius Hennch, et al.
Pageof 50

Showing results (451-460 of 491) with videos related to

Sort By:
Pageof 50
Wiener Klinische Wochenschrift|December 1, 2021
[Guideline S1: Long COVID: Diagnostics and treatment strategies]Susanne Rabady, Johann Altenberger, Markus Brose, et al.
Wiener Klinische Wochenschrift|August 9, 2023
[S1 guidelines for the management of postviral conditions using the example of post-COVID-19]Susanne Rabady, Kathryn Hoffmann, Martin Aigner, et al.
Wiener Klinische Wochenschrift|December 3, 2020
Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statementDiana Bonderman, Gerhard Pölzl, Klemens Ablasser, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2013
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohortTomas Olsson, Anat Achiron, Lars Alfredsson, et al.
Atherosclerosis|June 29, 2015
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) SocietyCharalambos Vlachopoulos, Panagiotis Xaplanteris, Victor Aboyans, et al.
Hemasphere|January 14, 2022
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell LymphomaRoch Houot, Viola Poeschel, Bettina Altmann, et al.
Journal of Hematology & Oncology|May 21, 2026
Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysisNico Gagelmann, Hermann Einsele, Sarah Flossdorf, et al.
European Heart Journal|August 17, 2025
Accelerated vascular ageing after COVID-19 infection: the CARTESIAN studyRosa Maria Bruno, Smriti Badhwar, Leila Abid, et al.
Journal of Clinical Medicine|July 18, 2020
Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot SpotsMichaela Auer-Grumbach, Rene Rettl, Klemens Ablasser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2023
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient OutcomesDaniel Noerenberg, Franziska Briest, Cornelius Hennch, et al.
Pageof 50